MicroPort EP

What MicroPort EP does

Shanghai MicroPort EP MedTech Co., Ltd. (微创电生理, ticker 688351.SH) is a China-based medical device company that develops and commercializes a full portfolio of cardiac electrophysiology products used by hospitals and cardiac centers to diagnose and treat cardiac arrhythmias, primarily atrial fibrillation. The company is a subsidiary of MicroPort Scientific Corporation, headquartered in Shanghai's Pudong New Area, and employs 101-250 people.

MicroPort EP's product platform is organized around five energy and navigation modalities: 3D cardiac mapping (Columbus® system), radiofrequency ablation (FireMagic® catheter family, OptimAblate® generator), pulsed field ablation (PulseMagic™ generator and TrueForce®/Spiral catheters), cryoablation (IceMagic® generator and balloon catheter), and robotic magnetic navigation (Magbot™ catheter integrated with the distributed Genesis RMN™ and Niobe® platforms). Supporting the ablation workflow are diagnostic mapping catheters (EasyFinder®, EasyLoop®, EasyStars®, EasyPaddle®), intracardiac echocardiography (EasyEcho™) with the AI-ICE intelligent cardiac modeling feature, and access devices (PathBuilder® sheaths and needles). The integrated ecosystem is marketed as a 'five-technology' (Electric-Fire-Ice-Magnetic-Sound) solution covering the full EP procedure workflow from mapping to ablation to imaging.

The company sells hardware and single-use consumables directly to hospitals and cardiac centers in China, with an emerging international footprint evidenced by the June 2025 European commercial launch of Magbot™ magnetic navigation products. Marketing is conducted primarily through medical conferences (including CHRS 2026), specialist training programs on PFA and AI-ICE imaging, and a public investor relations program on the Shanghai Stock Exchange. Pricing is not publicly disclosed, and the company is majority-controlled by MicroPort Scientific Corporation.

Name

MicroPort EP

Legal name

Shanghai MicroPort EP MedTech Co., Ltd.

Website

https://ep.microport.com

Company type

Public

Founded year

2010

Operating status

Operating

Headcount range

101–250 employees

Short description

Shanghai MicroPort EP MedTech (688351.SH) develops and sells cardiac electrophysiology devices—including 3D mapping systems, RF, pulsed field, and cryoablation catheters, and robotic magnetic navigation systems—for hospitals and cardiac centers in China, with expanding international presence.

Ownership category

akta.pro rank

Product category

Cardiac Electrophysiology Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Electrophysiology Mapping & Ablation Systems (HLAHAFAD)

Keywords

• Cardiac electrophysiology devices
• Radiofrequency ablation catheters
• 3D cardiac mapping systems
• Cryoablation equipment
• Medical device manufacturing

Headquarters

HQ city

Shanghai

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales

Revenue model

1. Medical Device Sales: Sale of cardiac electrophysiology medical devices including mapping systems, ablation catheters, and supporting equipment to hospitals and healthcare providers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Shanghai MicroPort EP MedTech develops, manufactures, and markets a full-spectrum cardiac electrophysiology medical device portfolio for the interventional treatment of cardiac arrhythmias. Its offering spans 3D cardiac mapping systems (Columbus®), radiofrequency ablation catheters (FireMagic®), pulsed field ablation systems and catheters (PulseMagic™), cryoablation systems and balloon catheters (IceMagic®), and robotic magnetic navigation platforms (Magbot™, Genesis RMN™, Niobe®), supported by diagnostic mapping catheters, intracardiac echocardiography (EasyEcho™), and transseptal access devices (PathBuilder®).

Product overview

Shanghai MicroPort EP MedTech Co., Ltd. (微创电生理) offers a comprehensive portfolio of cardiac electrophysiology medical devices and solutions organized into five main categories: 3D Solutions (centered on Columbus® 3D mapping system), 2D Solutions (FireMagic® ablation catheters and EasyFinder® mapping catheters), Pulse Solutions (PulseMagic™ pulse field ablation system with TrueForce® and Spiral catheters), Cryo Solutions (IceMagic® cryoablation system with balloon catheters), and Magnetic Navigation Robot Solutions (Magbot™ ablation catheter integrated with distributed Genesis RMN™ and Niobe® robotic platforms). The portfolio includes diagnostic mapping catheters (EasyPaddle®, EasyStars®, EasyLoop®, EasyEcho™ ICE imaging), radiofrequency ablation catheters (FireMagic® family), access devices (PathBuilder® sheath and needle systems), and support equipment (OptimAblate® ablation generator and perfusion pump). The company provides an integrated intervention diagnostic solution encompassing mapping, ablation, imaging, and robotic navigation technologies for treating cardiac arrhythmias.

Differentiator

Problem solved

Functional benefit

Brands

• Columbus®: Three-dimensional cardiac electrophysiology mapping system
• FireMagic®
• EasyPaddle®
• EasyStars®
• EasyEcho™
• OptimAblate®
• PulseMagic™
• IceMagic®
• Magbot™
• PathBuilder®
• Genesis RMN™
• Niobe®
• Odyssey Vision™

Products and services

• Columbus® 3D Cardiac Electrophysiology Mapping System Three-dimensional cardiac electrophysiology mapping system for visualizing and mapping cardiac electrical activity during electrophysiology procedures, used by hospitals and cardiac centers performing arrhythmia diagnosis and ablation.
• OptimAblate® Cardiac Radiofrequency Ablation System Cardiac radiofrequency ablation generator for treating cardiac arrhythmias through controlled thermal energy delivery, used by electrophysiology labs performing RF ablation procedures.
• OptimAblate® Perfusion Pump Perfusion pump accessory used to deliver saline irrigation during radiofrequency ablation procedures in electrophysiology labs.
• FireMagic® TrueForce® Pressure-Monitoring Magnetic Positioning RF Ablation Catheter Single-use radiofrequency ablation catheter with integrated real-time pressure monitoring and magnetic positioning for precise cardiac ablation, used by electrophysiology specialists for arrhythmia treatment.
• FireMagic® Cardiac Radiofrequency Ablation Catheter Family Family of standard, cool saline irrigation, 3D magnetic positioning, microelectrode, and SuperCool cardiac radiofrequency ablation catheters for treating arrhythmias through controlled thermal energy delivery.
• EasyFinder®, EasyLoop®, EasyPaddle®, EasyStars® Cardiac Mapping Catheter Family Family of single-use diagnostic cardiac mapping catheters — including adjustable curvature (EasyFinder®), loop (EasyLoop®), mesh (EasyPaddle®), and star-shaped (EasyStars®) magnetic-electrical positioning designs — used by electrophysiologists for detailed cardiac electrical mapping.
• EasyEcho™ Intracardiac Echocardiography Catheter Single-use intracardiac ultrasound imaging catheter that provides real-time echocardiographic imaging during cardiac procedures, used by EP specialists for procedural guidance and integration with the AI-ICE智能建模 smart cardiac modeling technology.
• PathBuilder® Transseptal Sheath and Needle Access System Family of transseptal puncture sheaths, needles, and adjustable curvature introducer sheath sets used to access the left atrium and guide catheters during cardiac electrophysiology interventions.
• PulseMagic™ Cardiac Pulse Field Ablation System Cardiac pulse field ablation system using irreversible electroporation via pulsed electric fields for atrial fibrillation treatment, sold as a complete ablation equipment offering for EP labs.
• PulseMagic™ TrueForce® and Spiral Pulse Field Ablation Catheters Single-use pressure-monitoring (TrueForce®) and spiral magnetic-electrical positioning cardiac pulse field ablation catheters used with the PulseMagic™ PFA system for atrial fibrillation treatment.
• IceMagic® Cryoablation System Cryoablation generator equipment for treating cardiac arrhythmias through controlled freezing of cardiac tissue, used in electrophysiology labs as part of the company's Cryo Solution line.
• IceMagic® Balloon Cryoablation Catheter Balloon-based single-use cryoablation catheter used with the IceMagic® generator for controlled freezing of cardiac tissue during arrhythmia treatment procedures.
• Magbot™ Magnetic Navigation Saline Irrigation RF Ablation Catheter Single-use magnetic navigation saline irrigation RF ablation catheter designed for robotic-assisted cardiac ablation procedures, integrated with the Genesis RMN™ and Niobe® robotic magnetic navigation platforms.
• Genesis RMN™ and Niobe® Robotic Magnetic Navigation Systems Cardiac electrophysiology robotic magnetic navigation platforms (Genesis RMN™ and Niobe®) for remote-controlled, minimally invasive arrhythmia ablation procedures, distributed in China and integrated with the Magbot™ catheter.
• Odyssey Vision™ Catheter Lab Video Image Integration System Catheterization laboratory video image integration system distributed by MicroPort EP to provide procedural visualization support for electrophysiology workflows.

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Biosense Webster (Johnson & Johnson): Biosense Webster is the global leader in cardiac electrophysiology, offering CARTO 3D mapping, Thermocool/Smart-Touch RF ablation catheters, and the recently launched VARIPULSE PFA platform. Direct competitor to MicroPort EP across mapping and ablation, with substantially larger R&D and global footprint.
• Abbott (Cardiac Arrhythmias & Heart Failure): Abbott's EP division (post-St. Jude Medical acquisition) competes with EnSite X 3D mapping, TactiCath/TactiFlex ablation catheters, and the Volt PFA system. Direct overlap with MicroPort EP across the full EP procedure workflow.
• Boston Scientific: Boston Scientific offers the Rhythmia HDx mapping system, IntellaNav ablation catheters, and the FARAPULSE PFA platform — a leading global PFA competitor. Directly comparable portfolio to MicroPort EP across mapping, RF, and PFA.
• Medtronic: Medtronic's Cardiac Diagnostics & Services offers the CardioInsight mapping system, Affera Prism-1 PFA platform (acquired 2022), and DiamondTemp RF ablation. Competes with MicroPort EP across all major EP modalities.

Direct peers

• Stereotaxis: Stereotaxis manufactures the Genesis RMN and Niobe magnetic navigation robotic systems that MicroPort EP distributes in China. The underlying IP owner of MicroPort EP's robotic EP offering, making it a direct technology partner and competitor in the robotic EP segment.
• Shanghai HeartCare Medical Technology (心诺普医疗): Shanghai HeartCare Medical Technology is a Chinese EP-focused medical device company offering mapping and ablation catheters. Closest direct domestic competitor to MicroPort EP within the Chinese market, with overlapping product lines in diagnostic and ablation catheters.
• Jinjiang Electronic Technology (锦江电子): Sichuan Jinjiang Electronic Science & Technology is a Chinese EP device company with RF ablation and cryoablation systems targeting the same Chinese hospital customers as MicroPort EP. Directly comparable domestic competitor in EP ablation technology.

Emerging players

• Acutus Medical: Acutus Medical developed the AcQMap high-resolution mapping system and a PFA platform before restructuring. Comparable as an emerging player in EP mapping and ablation technology targeting similar clinical use cases as MicroPort EP's Columbus® and PulseMagic™.
• CathVision: CathVision develops the ECGenius electrophysiology recording and 3D mapping system as a lower-cost alternative to incumbent mapping platforms. Emerging player addressing the same EP procedure workflow as MicroPort EP's Columbus® system.
• Galvanize Therapeutics: Galvanize Therapeutics is developing pulsed electric field and thermal ablation technologies for cardiac arrhythmias. Emerging PFA-focused player with overlapping technology approach to MicroPort EP's PulseMagic™ system.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MicroPort EP